Loading...

Ocumetics Technology Corp.

OTCFFPNK
Healthcare
Medical - Instruments & Supplies
$0.39
$-0.01(-1.43%)
U.S. Market opens in 51h 40m

Ocumetics Technology Corp. Fundamental Analysis

Ocumetics Technology Corp. (OTCFF) shows weak financial fundamentals with a PE ratio of -13.43, profit margin of 0.00%, and ROE of 1.38%. The company generates N/A in annual revenue with weak year-over-year growth of 0.00%.

Key Strengths

PEG Ratio0.27

Areas of Concern

ROE1.38%
Operating Margin0.00%
Cash Position0.93%
Current Ratio0.23
We analyze OTCFF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 54.5/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
54.5/100

We analyze OTCFF's fundamental strength across five key dimensions:

Efficiency Score

Weak

OTCFF struggles to generate sufficient returns from assets.

ROA > 10%
-2.66%

Valuation Score

Excellent

OTCFF trades at attractive valuation levels.

PE < 25
-13.43
PEG Ratio < 2
0.27

Growth Score

Weak

OTCFF faces weak or negative growth trends.

Revenue Growth > 5%
0.00%
EPS Growth > 10%
-58.73%

Financial Health Score

Moderate

OTCFF shows balanced financial health with some risks.

Debt/Equity < 1
-1.34
Current Ratio > 1
0.23

Profitability Score

Weak

OTCFF struggles to sustain strong margins.

ROE > 15%
137.97%
Net Margin ≥ 15%
0.00%
Positive Free Cash Flow
No

Key Financial Metrics

Is OTCFF Expensive or Cheap?

P/E Ratio

OTCFF trades at -13.43 times earnings. This suggests potential undervaluation.

-13.43

PEG Ratio

When adjusting for growth, OTCFF's PEG of 0.27 indicates potential undervaluation.

0.27

Price to Book

The market values Ocumetics Technology Corp. at -17.27 times its book value. This may indicate undervaluation.

-17.27

EV/EBITDA

Enterprise value stands at -5.97 times EBITDA. This is generally considered low.

-5.97

How Well Does OTCFF Make Money?

Net Profit Margin

For every $100 in sales, Ocumetics Technology Corp. keeps $0.00 as profit after all expenses.

0.00%

Operating Margin

Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.

0.00%

ROE

Management delivers $1.38 in profit for every $100 of shareholder equity.

1.38%

ROA

Ocumetics Technology Corp. generates $-2.66 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.66%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-0.03 in free cash annually.

$-0.03

FCF Yield

OTCFF converts -12.84% of its market value into free cash.

-12.84%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-13.43

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.27

vs 25 benchmark

P/B Ratio

Price to book value ratio

-17.27

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.34

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.23

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

1.38

vs 25 benchmark

ROA

Return on assets percentage

-2.66

vs 25 benchmark

ROCE

Return on capital employed

1.59

vs 25 benchmark

How OTCFF Stacks Against Its Sector Peers

MetricOTCFF ValueSector AveragePerformance
P/E Ratio-13.4329.94 Better (Cheaper)
ROE137.97%738.00% Weak
Net Margin0.00%-575975.00% (disorted) Weak
Debt/Equity-1.340.44 Strong (Low Leverage)
Current Ratio0.234.49 Weak Liquidity
ROA-266.27%-15756.00% (disorted) Weak

OTCFF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Ocumetics Technology Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

23.76%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

-9982.26%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ